Influence of anti-TNF-α treatment on liver and kidney functions in patients with ankylosing spondylitis: A retrospective longitudinal study.
Lütfi AkyolMehmet Ali BalciPublished in: European journal of rheumatology (2021)
No hepatotoxicity or nephrotoxicity were found in association with the use of anti-TNF-α agents over a 1 year period. However, hepatotoxicity and nephrotoxicity are among known adverse effects of these agents. Based on the existing literature data, routine monitoring of patients in terms of potential hepatic and renal toxicity before and after treatment remains a valid recommendation in clinical practice.
Keyphrases
- ankylosing spondylitis
- clinical practice
- rheumatoid arthritis
- drug induced
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- systematic review
- disease activity
- prognostic factors
- electronic health record
- oxidative stress
- peritoneal dialysis
- emergency department
- systemic lupus erythematosus
- machine learning
- combination therapy
- big data
- smoking cessation
- human health
- deep learning
- data analysis
- adverse drug